Published results from the 96-Week Phase 2b SYMMETRY trial in
the New England Journal of Medicine
Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Seeking Alpha / 47 minutes from now 1 Views
Seeking Alpha / 47 minutes from now 1 Views
Published results from the 96-Week Phase 2b SYMMETRY trial in
the New England Journal of Medicine
Comments